Overexpressed LEDGF is a novel biomarker of poor prognosis in patients with cervical cancer.

In conclusion, the present results suggest that LEDFG expression is an independent prognostic biomarker for cervical cancer. PMID: 29953789 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/29953789?dopt=Abstract

Source: European Journal of Gynaecological Oncology - July 1, 2018 Category: OBGYN Tags: Eur J Gynaecol Oncol Source Type: research